BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32942346)

  • 1. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications.
    Yatham LN; Vieta E; McIntyre RS; Jain R; Patel M; Earley W
    Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies.
    McIntyre RS; Suppes T; Earley W; Patel M; Stahl SM
    CNS Spectr; 2020 Aug; 25(4):502-510. PubMed ID: 31576791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis.
    Jain R; McIntyre RS; Cutler AJ; Earley WR; Nguyen HB; Adams JL; Yatham LN
    Int Clin Psychopharmacol; 2024 Mar; 39(2):82-92. PubMed ID: 37551609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies.
    Patel M; Jain R; Tohen M; Maletic V; Earley WR; Yatham LN
    Int Clin Psychopharmacol; 2021 Mar; 36(2):76-83. PubMed ID: 33230026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
    Earley W; Burgess MV; Rekeda L; Dickinson R; Szatmári B; Németh G; McIntyre RS; Sachs GS; Yatham LN
    Am J Psychiatry; 2019 Jun; 176(6):439-448. PubMed ID: 30845817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
    Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression.
    Earley WR; Burgess M; Rekeda L; Hankinson A; McIntyre RS; Suppes T; Calabrese JR; Yatham LN
    J Affect Disord; 2020 Feb; 263():386-395. PubMed ID: 31969269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS; Masand PS; Earley W; Patel M
    J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
    Earley WR; Burgess MV; Khan B; Rekeda L; Suppes T; Tohen M; Calabrese JR
    Bipolar Disord; 2020 Jun; 22(4):372-384. PubMed ID: 31628698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
    Durgam S; Earley W; Lipschitz A; Guo H; Laszlovszky I; Németh G; Vieta E; Calabrese JR; Yatham LN
    Am J Psychiatry; 2016 Mar; 173(3):271-81. PubMed ID: 26541814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
    Earley W; Durgam S; Lu K; Ruth A; Németh G; Laszlovszky I; Yatham LN
    J Affect Disord; 2018 Jan; 226():239-244. PubMed ID: 29017067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.
    Vieta E; Durgam S; Lu K; Ruth A; Debelle M; Zukin S
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1882-91. PubMed ID: 26419293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder.
    Citrome L; Li C; Yu J; Kramer K; Nguyen HB
    J Affect Disord; 2024 Aug; 358():353-360. PubMed ID: 38657773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
    Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
    Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
    J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Sachs GS; Yeung PP; Rekeda L; Khan A; Adams JL; Fava M
    Am J Psychiatry; 2023 Mar; 180(3):241-251. PubMed ID: 36789515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist.
    Citrome L
    Clin Schizophr Relat Psychoses; 2016; 10(2):109-19. PubMed ID: 27440212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study.
    Riesenberg R; Yeung PP; Rekeda L; Sachs GS; Kerolous M; Fava M
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37585254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.